Form EFFECT Alamar Biosciences, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 20, 2026 |
| Accession Number: | 0001193125-26-162823 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fireply AI Launches a New Platform to Help Brands Navigate Declining Organic Social Reach in 2026
- ELEKTROS Inc. Positions Itself for Strategic Growth as the Company Advances Its Vision for a High-Speed EV Charging Network
- Best Crypto Presale 2026: CLARITY Act Nears Deadline as Pepeto Raises $10.3 Million Before Listing
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
